Supramolecular Nanofibers Containing Arginine-Glycine-Aspartate (RGD) Peptides Boost Therapeutic Efficacy of Extracellular Vesicles in Kidney Repair
Chuyue Zhang,Yuna Shang,Xiaoniao Chen,Adam C. Midgley,Zhongyan Wang,Dashuai Zhu,Jie Wu,Pu Chen,Lingling Wu,Xu Wang,Kaiyue Zhang,Hongfeng Wang,Deling Kong,Zhimou Yang,Zongjin Li,Xiangmei Chen
DOI: https://doi.org/10.1021/acsnano.0c05681
IF: 17.1
2020-08-11
ACS Nano
Abstract:Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSC-EVs) have been recognized as a promising cell-free therapy for acute kidney injury (AKI), which avoids safety concerns associated with direct cell engraftment. However, low stability and retention of MSC-EVs have limited their therapeutic efficacy. RGD (Arg-Gly-Asp) peptide binds strongly to integrins, which have been identified on the surface of MSC-EV membranes; yet RGD has not been applied to EV scaffolds to enhance and prolong bioavailability. Here, we developed RGD hydrogels, which we hypothesized could augment MSC-EV efficacy in the treatment of AKI models. <i>In vivo</i> tracking of the labeled EVs revealed that RGD hydrogels increased retention and stability of EVs. Integrin gene knockdown experiments confirmed that EV–hydrogel interaction was mediated by RGD–integrin binding. Upon intrarenal injection into mouse AKI models, EV-RGD hydrogels provided superior rescuing effects to renal function, attenuated histopathological damage, decreased tubular injury, and promoted cell proliferation in early phases of AKI. RGD hydrogels also augmented antifibrotic effects of MSC-EVs in chronic stages. Further analysis revealed that the presence of microRNA let-7a-5p in MSC-EVs served as the mechanism contributing to the reduced cell apoptosis and elevated cell autophagy in AKI. In conclusion, RGD hydrogels facilitated MSC-derived let-7a-5p-containing EVs, improving reparative potential against AKI. This study developed an RGD scaffold to increase the EV integrin-mediated loading and in turn improved therapeutic efficacy in renal repair; therefore this strategy shed light on MSC-EV application as a cell-free treatment for potentiated efficiency.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c05681?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c05681</a>.<sup>1</sup>H NMR spectrum of biotin-GFFYGRGD; HR-MS spectrum of RGD-biotin molecule; <sup>1</sup>H NMR spectrum of biotin-GFFYG; HR-MS spectrum of biotin molecule; dynamic frequency sweep of EV/RGD hydrogel encapsulating EVs at different mass ratios; dynamic frequency sweep of RGD hydrogel before and after encapsulation of EVs; percentage of compound <b>1</b> remaining after treating with protease K; <i>in vivo</i> retention time of 100 μM Cy5.5/RGD-biotin hydrogel; TEM image of biotin hydrogel formed by biotin molecule; biocompatibility of RGD hydrogel; representative H&E-stained kidney sections on day 3 following IRI; primers used for real-time RT-PCR (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05681/suppl_file/nn0c05681_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology